##  [Brexit: Possible Outcomes   
for Life Sciences](/index%2ephp/webinars/brexit-possible-outcomes-for-life-sciences) 

<a>Medical Devices</a>



<a>Past Webinar</a>



## **Brexit: Possible Outcomes for Life Sciences**

**The webinar was successfully concluded on**

  **November 11, 2020.**

[Download Webinar](javascript:void(0))





We are delighted to see your interest in Freyr’s Webinar Series (FWS). The webinar on, **“Brexit: Possible Outcomes for Lifesciences”**, was successfully concluded on November 11, 2020. Here is the archived session for your perusal.

#### What Was It All About?

In a nutshell, during the webinar, our presenter - **Christopher Carr (**Associate Director), discussed about:

- Various Possible Scenarios / Trade Deal Types That Might Formalize and Surround the UK’s Exit from the EU
- Major Areas of Pharmaceutical Business that Might Be Affected
- Q&amp;A / What Do You Need to Do, To Stay Ahead of the Curve

As a continuous practice, Freyr is destined to organize more webinar sessions related to Regulatory aspects of Life Sciences. We are sure you would like to be a part of all those sessions. If yes, we will be very much happy to inform you about the next session.